Post-transplant lymphoproliferative disorders: making sense of the proliferation of potential therapies
- PMID: 11930089
- DOI: 10.1097/00005176-200204000-00007
Post-transplant lymphoproliferative disorders: making sense of the proliferation of potential therapies
Comment on
-
Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):389-93. doi: 10.1097/00005176-200204000-00014. J Pediatr Gastroenterol Nutr. 2002. PMID: 11930095
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical